Mathilde Duchamp

Senior Associate

Paris

Mathilde Duchamp is a M&A, Private Equity and Capital Markets lawyer in Orrick’s Paris office.

Mathilde Duchamp specializes in corporate transactions, with a particular focus on mergers and acquisitions, disposals, private equity and capital markets transactions. She advises both French and international clients—across listed and unlisted companies—on all aspects of corporate law, including public offerings and market financing transactions. Mathilde is also experienced in preparing corporate documentation, particularly for M&A, corporate restructuring and capital markets transactions, such as mergers, asset contributions and capital increases.

Prior to joining Orrick, Mathilde was an associate at another international law firm in Paris.

Engagements
- Abivax in its US$747.5 million public offering on Nasdaq.*
- Affluent Medical in its acquisition by Caranx Medical and Artedrone.*
- Mauna Kea Technologies in its refinancing.*
- Archimed in its investment in Ceva Santé Animale.*
- Crossject in its capital increase and issuance of share subscription warrants.*
- Crown Holdings in its senior notes offering.*
- Vestiaire Collective in its crowdfunding campaign.*
- Abivax in the largest IPO on Nasdaq for a French biotech.*
- Abivax in the largest single-tranche capital increase on Euronext Paris.*
- Sofinnova Partners in its strategic partnership.*
- Vestiaire Collective in its acquisition of Tradesy.*
- Mayoly Spindler in its exclusive negotiations with Ipsen for the acquisition of the group's Consumer Healthcare business.*
*experience prior to joining Orrick

D: +33 1 5353 7286
E:[email protected]

Address:

61, rue des Belles Feuilles
Paris, 75116
France

vCard

Practices

Admitted In
- Paris

Education
- University Versailles - Saint Quentin, Master 2, Business Law, 2014, Merits
- Versailles Bar School - Haute Ecole des Avocats Conseils, Certificat d'Aptitude à la Profession d'Avocat, 2016

Languages
- French
- English